Adjunctive Antithrombotic Medications to Acute Reperfusion Therapy: Current Evidence and Future Directions
- 1 August 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (8) , 2369-2374
Abstract
Thrombolytics and mechanical thrombectomy are standard of care therapies for the treatment of acute ischemic stroke. Optimizing reperfusion beyond these 2 interventions is a critical next step to improving patient outcomes. The utility of antithrombotic medications is well-established for secondary stroke prevention, but their role as adjunctive therapies to achieve or optimize reperfusion in the acute setting remains investigational. This article discusses the rationale for the use of adjunctive antithrombotic medications in combination with reperfusion therapies and reviews key trials exploring their use. We will use the term adjunctive to refer to any antithrombotic intervention that is added acutely to the standard of care of thrombolysis or thrombectomy to improve patient outcomes. A brief discussion on the future of adjunctive therapies for current reperfusion strategies and the best use of antithrombotic medications in the hospital setting are additionally presented.Keywords
This publication has 20 references indexed in Scilit:
- Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic StrokeNew England Journal of Medicine, 2024
- Tirofiban for Stroke without Large or Medium-Sized Vessel OcclusionNew England Journal of Medicine, 2023
- Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion StrokeJAMA, 2022
- Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trialThe Lancet, 2022
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke AssociationStroke, 2019
- Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trialThe Lancet, 2012
- The C ombined Approach to L ysis Utilizing E ptifibatide a nd r t-PA in Acute Ischemic StrokeStroke, 2008
- Intra-arterial Prourokinase for Acute Ischemic StrokeJAMA, 1999
- PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery StrokeStroke, 1998
- Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic strokeThe Lancet, 1995